Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
2.430
+0.165 (7.28%)
Nov 4, 2024, 4:00 PM EST - Market closed
Syros Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for SYRS stock have an average target of 5.00, with a low estimate of 4.00 and a high estimate of 6.00. The average target predicts an increase of 105.76% from the current stock price of 2.43.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SYRS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +146.91% | Nov 1, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $12 → $4 | Buy | Maintains | $12 → $4 | +64.61% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $13 → $5 | Buy | Reiterates | $13 → $5 | +105.76% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +146.91% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +517.28% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
892.50K
from 9.94M
Decreased by -91.02%
Revenue Next Year
6.38M
from 892.50K
Increased by 614.29%
EPS This Year
-2.20
from -5.81
EPS Next Year
-2.86
from -2.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.7M | 21.0M | 89.3M | ||
| Avg | 892,500 | 6.4M | 43.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -63.0% | 2,252.9% | 1,300.0% | ||
| Avg | -91.0% | 614.3% | 580.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.09 | -1.98 | -1.47 | ||
| Avg | -2.20 | -2.86 | -1.88 | ||
| Low | -2.27 | -3.16 | -2.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.